Abrysvo Disease Interactions
There are 2 disease interactions with Abrysvo (rsv vaccine, pref a-pref b, recombinant).
RSV vaccine (applies to Abrysvo) immunodeficiency
Moderate Potential Hazard, Moderate plausibility.
Immunocompromised individuals, including those receiving immunosuppressive therapy, may have a diminished immune response to the RSV vaccine.
References (3)
- (2024) "Product Information. Mresvia Prefilled Syringe (cvx 326) (RSV mRNA vaccine (cvx 326))." Moderna US, Inc
- (2024) "Product Information. Arexvy (RSV vaccine preF3, recombinant)." GlaxoSmithKline
- (2025) "Product Information. Abrysvo (RSV vaccine, preF A-preF B, recombinant)." Pfizer U.S. Pharmaceuticals Group, STN 125769/388
RSV vaccine (applies to Abrysvo) syncope
Moderate Potential Hazard, Moderate plausibility.
Syncope may occur in association with administration of injectable vaccines, including the RSV vaccine. Procedures should be in place to avoid injury from fainting, especially for patients who have previously fainted in association with an injection.
References (3)
- (2024) "Product Information. Mresvia Prefilled Syringe (cvx 326) (RSV mRNA vaccine (cvx 326))." Moderna US, Inc
- (2024) "Product Information. Arexvy (RSV vaccine preF3, recombinant)." GlaxoSmithKline
- (2025) "Product Information. Abrysvo (RSV vaccine, preF A-preF B, recombinant)." Pfizer U.S. Pharmaceuticals Group, STN 125769/388
Switch to consumer interaction data
Abrysvo drug interactions
There are 303 drug interactions with Abrysvo (rsv vaccine, pref a-pref b, recombinant).
Report options
More about Abrysvo (rsv vaccine, pref a-pref b, recombinant)
- Abrysvo consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Latest FDA alerts (1)
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: viral vaccines
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Arexvy
Arexvy is a vaccine used to prevent respiratory syncytial virus (RSV) lower respiratory tract ...
Beyfortus
Beyfortus is used to prevent respiratory syncytial virus (RSV) lower respiratory tract disease in ...
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
mRESVIA
mRESVIA is a vaccine used to immunize adults aged 60 years and older against lower respiratory ...
Synagis
Synagis is used to prevent lung disease caused by respiratory syncytial virus. Learn about side ...
Enflonsia
Enflonsia is an FDA-approved medication used to prevent respiratory syncytial virus (RSV) lower ...
Rsv vaccine pref3, recombinant
Rsv vaccine pref3, recombinant is used for RSV, RSV Vaccination and Immunization
Nirsevimab
Nirsevimab information from Drugs.com, includes Nirsevimab side effects, interactions and indications.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
